N-Me-aminopyrimidinone9
CAS No. 1356834-62-2
N-Me-aminopyrimidinone9 ( —— )
Catalog No. M21974 CAS No. 1356834-62-2
N-Me-aminopyrimidinone9 is a sodium channel antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 177 | In Stock |
|
5MG | 268 | In Stock |
|
10MG | 408 | In Stock |
|
25MG | 672 | In Stock |
|
50MG | 945 | In Stock |
|
100MG | 1278 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Me-aminopyrimidinone9
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Me-aminopyrimidinone9 is a sodium channel antagonist.
-
DescriptionN-Me-aminopyrimidinone9 is a sodium channel antagonist.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1356834-62-2
-
Formula Weight303.4
-
Molecular FormulaC16H21N3OS?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCn1c(SCc2ccc(cc2)C(C)(C)C)nc(N)cc1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VX-150
VX-150 is a highly selective NaV1.8 inhibitor relative to the other sodium channel subtypes (>400-fold).
-
Flecainide acetate
A class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias, works by blocking the Nav1.5 sodium channel in the heart.
-
Levobupivacaine
Levobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide.